Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

REPLIGEN CORP Director's Dealing 2010

Sep 28, 2010

30826_dirs_2010-09-28_ffadc540-ae92-4ec4-bbe2-54ddc27983e7.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: REPLIGEN CORP (RGEN)
CIK: 0000730272
Period of Report: 2010-09-16

Reporting Person: Goldberg Alfred Lewis (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2010-09-16 Stock Option (Right to Buy) $3.30 A 20000 Acquired 2020-09-16 Common Stock (20000) Direct

Footnotes

F1: Award represents Annual Board Options issued each September to each non-employee director. Award vests in full one year from grant date on September 16, 2011.